Skip to main content

Published locations for Atezolizumab combo in first-line NSCLC misses cost-effectiveness mark

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Atezolizumab combo in first-line NSCLC misses cost-effectiveness mark

User login

  • Reset your password
  • /content/atezolizumab-combo-first-line-nsclc-misses-cost-effectiveness-mark
  • /oncologypractice/article/204683/lung-cancer/atezolizumab-combo-first-line-nsclc-misses-cost
  • /hematology-oncology/article/204683/lung-cancer/atezolizumab-combo-first-line-nsclc-misses-cost